SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001011240-99-000041
Filing Date
1999-06-07
Accepted
1999-06-07 00:00:00
Documents
8
Period of Report
1999-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED 03/31/99 10-K 174941
2 EXHIBIT 4(H) - FIRST AMENDMENT TO LOAN AGREEMENT EX-4 15870
3 EXHIBIT 4(I) - SECOND AMENDMENT TO LOAN AGREEMENT EX-4 24153
4 EXHIBIT 10(EE) - AMENDMENT TO EMPLOYMENT AGREEMENT EX-10 3591
5 EXHIBIT 10(FF) - EXCLUSIVE LICENSE AGREEMENT EX-10 16099
6 EXHIBIT 21 - LIST OF SUBSIDIARIES EX-21 228
7 EXHIBIT 23 - CONSENT OF ACCOUNTANTS EX-23 595
8 FDS -- EX-27 2114
  Complete submission text file 0001011240-99-000041.txt   239810
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-09601 | Film No.: 99641682
SIC: 2834 Pharmaceutical Preparations